Hugli T E, Vallota E H, Müller-Eberhard H J
J Biol Chem. 1975 Feb 25;250(4):1472-8.
C3a anaphylatoxin is a protein fragment generated enzymatically in serum during activation of the third component of complement (C3). A four-step procedure is described for the purification of human and porcine C3a anaphylatoxins from their respective sera after activation with inulin. Because serum carboxypeptidase rapidly inactivates C3a, the inhibitor epsilon-aminocaproic acid (EACA) was added during C3 activation, thus permitting isolation of fully active C3a anaphylatoxins directly from serum. A 2000-fold purification of C3a was achieved with an average 30% recovery assuming total conversion of C3 during treatment of serum with inulin. Human C3a anaphylatoxin obtained through the action of the C3 activating enzyme of the "alternate" pathway appeared nearly identical with the C3a obtained from isolated C3 after treatment with the C4,2 enzyme of the "classical" pathway or with trypsin. Comparisons were made between various properties of human and porcine C3a anaphylatoxins. The molecular weights differed only slightly. Electrophoresis on a cellulose acetate strip at pH 8.6 indicated a difference of approximately one net charge between human and porcine C3a, with the human anaphylatoxin exhibiting the more basic behavior. Although the amino acid compositions are similar, significant differences exist. The most marked difference was the total absence of threonine residues in porcine C3a. The NH2-terminal sequences of 20 amino acid residues were examined; homology existed for 16 of the 20 positions. Although partial analysis of the primary structure of human and porcine C3a indicates approximately 80% homology, no immunological cross-reactivity between the anaphylatoxins could be detected with antisera produced to either human or porcine C3a. In spite of the structural differences, the biological activities of porcine and human C3a were essentially identical. Smooth muscle contraction, increase in vascular permeability, and release of histamine from mast cells were similarly induced by equal amounts of anaphylatoxin from either human or porcine origin. Porcine C3a, like human C3a, was shown to contain a COOH-terminal arginyl residue essential for smooth muscle contraction and for induction of histamine release from mast cells. The sequence adjacent to the COOH-terminal arginine was Leu-Ala-Arg-COOH for both humans and porcine C3a. Current evidence suggests common mechanisms exist for the generation of C3a in various animal species and that the two known C3 activating enzymes in serum exhibit trypsin-like specificity.
C3a过敏毒素是补体第三成分(C3)激活过程中在血清中酶促产生的一种蛋白质片段。本文描述了一种四步法,用于从菊粉激活后的人血清和猪血清中纯化人及猪C3a过敏毒素。由于血清羧肽酶能迅速使C3a失活,因此在C3激活过程中添加了抑制剂ε-氨基己酸(EACA),从而可以直接从血清中分离出完全活性的C3a过敏毒素。假定在用菊粉处理血清过程中C3完全转化,C3a实现了2000倍的纯化,平均回收率为30%。通过“替代”途径的C3激活酶作用获得的人C3a过敏毒素,与经“经典”途径的C4,2酶或胰蛋白酶处理后从分离的C3中获得的C3a几乎相同。对人及猪C3a过敏毒素的各种特性进行了比较。分子量仅略有差异。在pH 8.6的醋酸纤维素条上进行电泳表明,人及猪C3a之间的净电荷差异约为一个,人过敏毒素表现出更碱性的行为。尽管氨基酸组成相似,但仍存在显著差异。最明显的差异是猪C3a中完全没有苏氨酸残基。检测了20个氨基酸残基的NH2末端序列;20个位置中有16个存在同源性。尽管对人及猪C3a一级结构的部分分析表明同源性约为80%,但用人或猪C3a产生的抗血清均未检测到过敏毒素之间的免疫交叉反应。尽管存在结构差异,但猪和人C3a的生物学活性基本相同。等量的人源或猪源过敏毒素同样能诱导平滑肌收缩、血管通透性增加以及肥大细胞释放组胺。猪C3a与人C3a一样,被证明含有一个对平滑肌收缩和诱导肥大细胞释放组胺至关重要的COOH末端精氨酰残基。人和猪C3a的COOH末端精氨酸相邻序列均为Leu-Ala-Arg-COOH。目前的证据表明,各种动物物种中C3a的产生存在共同机制,并且血清中两种已知的C3激活酶表现出胰蛋白酶样特异性。